Remdesivir is superior to the standard of care for the treatment of COVID-19, according to a preliminary analysis based on data from a randomized, controlled trial. Researchers found that the antiviral was most beneficial for hospitalized patients with severe disease who required supplemental oxygen.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/05/200526111257.htm
No comments:
Post a Comment